Patent ID: 11959099
Assignee: HAJIME MORI
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 7:
8. The method according to claim 1 wherein said neurotrophic growth factor comprises a polypeptide comprising:
(i) full length NGF according to SEQ ID NO: 1 or mature NGF according to SEQ ID NO: 2 or homologues and/or fragments thereof with at least 90% sequence identity to SEQ ID NO: 1 or SEQ ID NO: 2 that retains neurotrophic growth factor activity, and
(ii) a targeting portion comprising H1 (SEQ ID NO: 3) or VP3 (SEQ ID NO: 4) or homologues and/or fragments thereof with at least 90% sequence identity to SEQ ID NO: 3 or SEQ ID NO: 4 that retain tag activity.